Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
| ▸ | RAD52 | P43351 | 1/20 | 0.72 |
| ▸ | UBE2N | P61088 | 1/20 | 0.72 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.72 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.66 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
| ▸ | PLAU | P00749 | 5/20 | 0.51 |
| ▸ | PLG | P00747 | 2/20 | 0.51 |
| ▸ | PLAT | P00750 | 2/20 | 0.51 |
| ▸ | KLK1 | P06870 | 2/20 | 0.51 |
| ▸ | NQO2 | P16083 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 3/20 | 0.43 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroxystilbamidine SCHEMBL29439031 | 1.00 | KDM4E (0.72) | KDM4EPOLBMAPTRAD52UBE2N | |
| Hydroxystilbamidine SCHEMBL8482349 | 1.00 | KDM4E (0.72) | KDM4EPOLBMAPTRAD52UBE2N | |
| Hydroxystilbamidine SCHEMBL31614578 | 1.00 | KDM4E (0.72) | KDM4EPOLBMAPTRAD52UBE2N | |
| Hydroxystilbamidine SCHEMBL27618664 | 0.95 | KDM4E (0.67) | KDM4EPOLBMAPTRAD52UBE2N | |
| SCHEMBL14541861 | 0.91 | KDM4E (0.62) | KDM4EPOLBMAPTRAD52UBE2N | |
| SCHEMBL14340159 | 0.90 | KDM4E (0.61) | KDM4EPOLBMAPTRAD52UBE2N | |
| Hydroxystilbamidine SCHEMBL26114123 | 0.90 | KDM4E (0.77) | KDM4EPOLBMAPTRAD52UBE2N | |
| Hydroxystilbamidine SCHEMBL3338013 | 0.90 | KDM4E (0.77) | KDM4EPOLBMAPTRAD52UBE2N | |
| Hydroxystilbamidine SCHEMBL17224190 | 0.90 | KDM4E (0.77) | KDM4EPOLBMAPTRAD52UBE2N | |
| SCHEMBL14437186 | 0.88 | KDM4E (0.63) | KDM4EPOLBMAPTRAD52UBE2N |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3087 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069175-A1 | SAMPLE-TO-ANSWER DIAGNOSTIC SYSTEM FOR THE DETECTION OF CIRCULATING HISTONES IN WHOLE BLOOD | UNIV MARYLAND (US) | 2026-03-12 | — | — | US | claimed |
| US-12551149-B2 | Sample-to-answer diagnostic system for the detection of circulating histones in whole blood | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2026-02-17 | — | — | US | claimed |
| US-20230390405-A1 | SELECTIVE NERVE CELL DEACTIVATION | EXODUS TECHNOLOGY LTD. (IL) | 2023-12-07 | — | — | US | claimed |
| EP-4244340-A1 | SELECTIVE NERVE CELL DEACTIVATION | Tsuriel, Shlomo (IL) | 2023-09-20 | — | — | EP | claimed |
| WO-2023164252-A1 | ISOTHERMAL NUCLEIC ACID DETECTION ASSAYS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-08-31 | — | — | WO | claimed |
| US-20230063411-A1 | SAMPLE-TO-ANSWER DIAGNOSTIC SYSTEM FOR THE DETECTION OF CIRCULATING HISTONES IN WHOLE BLOOD | UNIVERSITY OF MARYLAND, COLLEGE PARK | 2023-03-02 | — | — | US | claimed |
| WO-2022101907-A1 | SELECTIVE NERVE CELL DEACTIVATION | TSURIEL SHLOMO (IL) | 2022-05-19 | — | — | WO | claimed |
| WO-2019051106-A1 | DETECTION AND IDENTIFICATION OF BACTERIA AND DETERMINATION OF ANTIBIOTIC SUSCEPTIBILITY USING BACTERIOPHAGE AND REPORTER MOLECULES | THE CHARLES STARK DRAPER LABORATORY INC. (US) | 2019-03-14 | — | — | WO | claimed |
| US-20190078133-A1 | DETECTION AND IDENTIFICATION OF BACTERIA AND DETERMINATION OF ANTIBIOTIC SUSCEPTIBILITY USING BACTERIOPHAGE AND REPORTER MOLECULES | CHARLES STARK DRAPER LABORATORY INC (US) | 2019-03-14 | — | — | US | claimed |
| CN-109342381-A | A kind of fluorescent dyeing reagent | 广州往圣生物科技有限公司 | 2019-02-15 | — | — | CN | claimed |
| EP-1339399-A2 | COMBINATIONS OF DRUGS (E.G., CHLORPROMAZINE AND PENTAMIDINE) FOR THE TREATMENT OF NEOPLASTIC DISORDERS | Combinatorx, Incorporated (US) | 2003-09-03 | — | — | EP | claimed |
| US-20020165261-A1 | Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders | ZALICUS INC. | 2002-11-07 | — | — | US | claimed |
| WO-2002081739-A2 | NON-ENZYMATIC LIPOSOME-LINKED CLOSELY SPACED ARRAY ELECTRODES ASSAY (NEL-ELA) FOR DETECTING AND QUANTIFYING NUCLEIC ACIDS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2002-10-17 | — | — | WO | claimed |
| WO-2002058684-A2 | COMBINATIONS OF DRUGS (E.G., CHLORPROMAZINE AND PENTAMIDINE) FOR THE TREATMENT OF NEOPLASTIC DISORDERS | COMBINATORX, INCORPORATED (US) | 2002-08-01 | — | — | WO | claimed |
| WO-2002058697-A1 | COMBINATIONS OF DRUGS (E.G., A BENZIMIDAZOLE AND PENTAMIDINE) FOR THE TREATMENT OF NEOPLASTIC DISORDERS | COMBINATORX, INCORPORATED (US) | 2002-08-01 | — | — | WO | claimed |
| US-20020072053-A1 | Immunoassay based on DNA replication using labeled primer | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2002-06-13 | — | — | US | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0316440-B1 | System and method for providing localized Mössbauer absorption in an organic medium | MILLS RANDELL L (US) | 1996-01-03 | — | — | EP | claimed |